Tumor cells followed a similar trend, increasing in CD74 MIF (β = 0.219, p = 0.005) and MIF CD44 (β = 0.190, p < 0.0001), further supporting their role as hubs of immune activation and tumor presence in advanced disease (32). Here, CD44 is linked to neoplasm.